Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Dessources

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Gynecologic Oncology Reports|April 18, 2024
Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: <i>CTNNB1</i> mutation as a potential driverSushmita Gordhandas, Arnaud Da Cruz Paula, Elizabeth C Kertowidjojo, et al.
Gynecologic Oncology|May 10, 2025
Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytologyMaureen E Byrne, Pier Selenica, Kimberly Dessources, et al.
Histopathology|February 12, 2020
Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiationFrancisco Beca, Ana P M Sebastiao, Fresia Pareja, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2021
ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatmentKimberly Dessources, Kathryn M Miller, Elizabeth Kertowidjojo, et al.
Gynecologic Oncology|August 21, 2020
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancerEmeline M Aviki, Jessica A Lavery, Kara Long Roche, et al.
Gynecologic Oncology|February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trialAaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Cancer Discovery|August 31, 2023
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic ImplicationsBritta Weigelt, Antonio Marra, Pier Selenica, et al.
Gynecologic Oncology|January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2020
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalitiesYouran Zou, Gulisa Turashvili, Robert A Soslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II StudyOliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Gynecologic Oncology Reports|April 18, 2024
Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: <i>CTNNB1</i> mutation as a potential driverSushmita Gordhandas, Arnaud Da Cruz Paula, Elizabeth C Kertowidjojo, et al.
Gynecologic Oncology|May 10, 2025
Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytologyMaureen E Byrne, Pier Selenica, Kimberly Dessources, et al.
Histopathology|February 12, 2020
Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiationFrancisco Beca, Ana P M Sebastiao, Fresia Pareja, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2021
ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatmentKimberly Dessources, Kathryn M Miller, Elizabeth Kertowidjojo, et al.
Gynecologic Oncology|August 21, 2020
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancerEmeline M Aviki, Jessica A Lavery, Kara Long Roche, et al.
Gynecologic Oncology|February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trialAaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Cancer Discovery|August 31, 2023
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic ImplicationsBritta Weigelt, Antonio Marra, Pier Selenica, et al.
Gynecologic Oncology|January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2020
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalitiesYouran Zou, Gulisa Turashvili, Robert A Soslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II StudyOliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
Pageof 2